| UNH Stock | | | EUR 515.90 0.00 0.00% |
Director
Dr. Valerie C. Montgomery Rice, M.D. serves as Independent Director of the Company. She is the President and Dean of the Morehouse School of Medicine, a medical school in Atlanta, Georgia, and has served in that capacity since 2014, and as the Executive Vice President and Dean from 2011 to 2014. Morehouse School of Medicine is among the nation leading educators of primary care physicians and was recently recognized as the top institution among U.S. medical schools for their social mission. Prior to joining Morehouse School of Medicine, she served as dean of the School of Medicine and Senior Vice President of health affairs at Meharry Medical College from March 2006 to June 2009, and the director of the Center for Women Health Research, one of the nation first research centers devoted to studying diseases that disproportionately impact women of color, from 2005 to 2011. Dr. Montgomery Rice also serves as a Council Member of the National Institute of Health, National Center for Advancing Translational Science, and previously on the National Institute of Health Minority Health and Health Disparities and Office of Research on Women Health advisory councils, and the Association of American Medical Colleges Council of Deans administrative board. Dr. Montgomery Rice is a member of the National Academy of Medicine and a renowned infertility specialist and women health researcher. since 2017.
| Age | 56 |
| Tenure | 8 years |
| Professional Marks | Ph.D |
| Phone | 952 936 1300 |
| Web | https://www.unitedhealthgroup.com |
Valerie Montgomery Rice is the President and Dean of the Morehouse School of Medicine, a medical school in Atlanta, Georgia, and has served in that capacity since 2014, and as the EVP and Dean from 2011 to 2014. Prior to joining Morehouse School of Medicine, she served as dean of the School of Medicine and Senior Vice President of Health Affairs at Meharry Medical College from March 2006 to June 2009, and the director of the Center for Women’s Health Research, one of the nation’s first research centers devoted to studying diseases that disproportionately impact women of color, from 2005 to 2011. Montgomery Rice also serves as a Council Member of the National Institute of Health National Center for Advancing Translational Science. Montgomery Rice is a Member of the National Academy of Medicine and a renowned infertility specialist and women’s health researcher
UnitedHealth Group Management Efficiency
The company has return on total asset
(ROA) of
0.0776 % which means that it generated a profit of $0.0776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.2535 %, meaning that it generated $0.2535 on every $100 dollars invested by stockholders. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities.
UnitedHealth Group Incorporated has accumulated 54.51
B in total debt with debt to equity ratio
(D/E) of 0.66, which is about average as compared to similar companies. UnitedHealth Group has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist UnitedHealth Group until it has trouble settling it off, either with new capital or with free cash flow. So, UnitedHealth Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UnitedHealth Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UnitedHealth to invest in growth at high rates of return. When we think about UnitedHealth Group's use of debt, we should always consider it together with cash and equity.
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. UNITEDHEALTH GROUP operates under Healthcare Plans classification in Germany and is traded on Frankfurt Stock Exchange. It employs 330000 people. UnitedHealth Group Incorporated (UNH) is traded on Frankfurt Exchange in Germany and employs 34 people.
Management Performance
UnitedHealth Group Leadership Team
Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gail Wilensky, Independent Director | |
| Richard Burke, Independent Chairman of the Board | |
| Valerie Rice, Independent Director | |
| Andrew Witty, President, Chief Executive Officer of Optum | |
| Sir Witty, CEO Director | |
| Stephen Hemsley, Non-Executive Chairman of the Board | |
| John Rex, Chief Financial Officer, Executive Vice President | |
| Dirk McMahon, Chief Executive Officer - UnitedHealthcare | |
| Zachary Sopcak, VP Relations | |
| John Noseworthy, Independent Director | |
| Jennifer Smoter, VP Officer | |
| William Ballard, Independent Director | |
| Glenn Renwick, Independent Director | |
| Rupert Bondy, Ex Officer | |
| Sandeep Dadlani, Ex Officer | |
| Michele Hooper, Independent Director | |
| Timothy Flynn, Independent Director | |
| Thomas Roos, Senior Vice President, Chief Accounting Officer | |
| Matthew Friedrich, Executive Vice President Chief Legal Officer | |
| D Wilson, Executive Vice President - Human Capital | |
| F McNabb, Independent Director | |
| Marianne Short, Executive Vice President Chief Legal Officer | |
| David Wichmann, CFO, Executive Vice President and Presidentident - UnitedHealth Group Operations | |
| Brian Thompson, Ex UnitedHealthcare | |
| James Barry, Director Pennsylvania | |
UnitedHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in UnitedHealth Stock
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock: Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
You can also try the
Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.